Modulation of the discriminative stimulus properties of cocaine by 5- HT(1B) and 5-HT(2C) receptors

P. M. Callahan, Kathryn Cunningham

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

The present study assessed compounds displaying affinity for 5-HT(1A), 5- HT(1B), 5-HT(2A) and 5-HT(2C) receptors for their ability to substitute for, enhance or antagonize the discriminative stimulus effects of cocaine (10 mg/kg) in rats. In substitution tests, the 5-HT(1A) receptor agonist 8- hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT; 0.2-1.6 mg/kg), the 5- HT(1A/B) receptor agonists RU 24969 (0.25-2 mg/kg) and CGS 12066B (2-16 mg/kg), the 5-HT(1B/2C) receptor agonists m-chlorophenylpiperazine (mCPP; 0.25-2 mg/kg) and m-trifluoromethylphenylpiperazine (TFMPP; 0.125-2 mg/kg), the 5-HT(2A/2C) receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2- aminopropane ([±]-DOB; 0.0625-0.5 mg/kg), the 5-HT(2C) receptor agonist MK 212 (0.25-1 mg/kg) and the nonselective 5-HT receptor agonist quipazine (1-8 mg/kg) engendered 30% to 70% cocaine-appropriate responding. The DA receptor antagonists SCH 23390 (0.025 or 0.05 mg/kg) and haloperidol (0.125 or 0.25 mg/kg) failed to block the partial substitution of RU 24969 (1 mg/kg) for cocaine. In combination tests, a fixed dose of either quipazine (4 mg/kg), RU 24969 (0.25, 0.5 or 1 mg/kg) or TFMPP (0.5 mg/kg) but not 8-OH-DPAT (0.4 mg/kg) or CGS 12066B (16 mg/kg) produced a leftward shift in the cocaine dose-response curve (0.625-5 mg/kg). In contrast, coadministration of either mCPP (0.25-2 mg/kg) or MK 212 (0.125-2 mg/kg) plus a dose of cocaine (5 mg/kg) that produced >85% cocaine-appropriate responding when given alone partially antagonized cocaine; mCPP (1 mg/kg) also produced a rightward shift in the cocaine dose-response curve. Neither 8-OH-DPAT (0.2-1.6 mg/kg), (±)- DOB (0.125-0.5 mg/kg) nor quipazine (2-8 mg/kg) blocked the cocaine stimulus. The 5-HT(1A) receptor antagonist NAN 190 (0.2-0.8 mg/kg), the 5-HT(2A/2C) receptor antagonist LY 53857 (0.5-4 mg/kg) and the 5-HT/DA receptor antagonist pirenperone (0.5-4 mg/kg) neither substituted for nor enhanced cocaine; however, pirenperone but not NAN 190 or LY 53857 partially blocked the cocaine (10 mg/kg) response. Although 5-HT receptor compounds do not substitute for cocaine, several 5-HT receptor agonists (i.e., the indole derivative RU 24969 and the arylpiperazines mCPP, MK 212, TFMPP and quipazine), but not antagonists, differentially modulate the stimulus effects of cocaine. Moreover, 5-HT(1B) and 5-HT(2C) receptors may be responsible for the observed enhancements and antagonisms, respectively, produced by the 5- HT receptor compounds, whereas 5-HT(1A) and 5-HT(2A) receptors do not appear to modulate the cocaine discrimination in rats.

Original languageEnglish (US)
Pages (from-to)1414-1424
Number of pages11
JournalJournal of Pharmacology and Experimental Therapeutics
Volume274
Issue number3
StatePublished - 1995

Fingerprint

Receptor, Serotonin, 5-HT2C
Cocaine
Serotonin
Quipazine
Serotonin Receptors
8-Hydroxy-2-(di-n-propylamino)tetralin
Receptor, Serotonin, 5-HT2A
Receptor, Serotonin, 5-HT1A
LY 53857
Serotonin Receptor Agonists
Receptor, Serotonin, 5-HT1B
Haloperidol

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{4c22747e484c48f688c9960a9d3ccd12,
title = "Modulation of the discriminative stimulus properties of cocaine by 5- HT(1B) and 5-HT(2C) receptors",
abstract = "The present study assessed compounds displaying affinity for 5-HT(1A), 5- HT(1B), 5-HT(2A) and 5-HT(2C) receptors for their ability to substitute for, enhance or antagonize the discriminative stimulus effects of cocaine (10 mg/kg) in rats. In substitution tests, the 5-HT(1A) receptor agonist 8- hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT; 0.2-1.6 mg/kg), the 5- HT(1A/B) receptor agonists RU 24969 (0.25-2 mg/kg) and CGS 12066B (2-16 mg/kg), the 5-HT(1B/2C) receptor agonists m-chlorophenylpiperazine (mCPP; 0.25-2 mg/kg) and m-trifluoromethylphenylpiperazine (TFMPP; 0.125-2 mg/kg), the 5-HT(2A/2C) receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2- aminopropane ([±]-DOB; 0.0625-0.5 mg/kg), the 5-HT(2C) receptor agonist MK 212 (0.25-1 mg/kg) and the nonselective 5-HT receptor agonist quipazine (1-8 mg/kg) engendered 30{\%} to 70{\%} cocaine-appropriate responding. The DA receptor antagonists SCH 23390 (0.025 or 0.05 mg/kg) and haloperidol (0.125 or 0.25 mg/kg) failed to block the partial substitution of RU 24969 (1 mg/kg) for cocaine. In combination tests, a fixed dose of either quipazine (4 mg/kg), RU 24969 (0.25, 0.5 or 1 mg/kg) or TFMPP (0.5 mg/kg) but not 8-OH-DPAT (0.4 mg/kg) or CGS 12066B (16 mg/kg) produced a leftward shift in the cocaine dose-response curve (0.625-5 mg/kg). In contrast, coadministration of either mCPP (0.25-2 mg/kg) or MK 212 (0.125-2 mg/kg) plus a dose of cocaine (5 mg/kg) that produced >85{\%} cocaine-appropriate responding when given alone partially antagonized cocaine; mCPP (1 mg/kg) also produced a rightward shift in the cocaine dose-response curve. Neither 8-OH-DPAT (0.2-1.6 mg/kg), (±)- DOB (0.125-0.5 mg/kg) nor quipazine (2-8 mg/kg) blocked the cocaine stimulus. The 5-HT(1A) receptor antagonist NAN 190 (0.2-0.8 mg/kg), the 5-HT(2A/2C) receptor antagonist LY 53857 (0.5-4 mg/kg) and the 5-HT/DA receptor antagonist pirenperone (0.5-4 mg/kg) neither substituted for nor enhanced cocaine; however, pirenperone but not NAN 190 or LY 53857 partially blocked the cocaine (10 mg/kg) response. Although 5-HT receptor compounds do not substitute for cocaine, several 5-HT receptor agonists (i.e., the indole derivative RU 24969 and the arylpiperazines mCPP, MK 212, TFMPP and quipazine), but not antagonists, differentially modulate the stimulus effects of cocaine. Moreover, 5-HT(1B) and 5-HT(2C) receptors may be responsible for the observed enhancements and antagonisms, respectively, produced by the 5- HT receptor compounds, whereas 5-HT(1A) and 5-HT(2A) receptors do not appear to modulate the cocaine discrimination in rats.",
author = "Callahan, {P. M.} and Kathryn Cunningham",
year = "1995",
language = "English (US)",
volume = "274",
pages = "1414--1424",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Modulation of the discriminative stimulus properties of cocaine by 5- HT(1B) and 5-HT(2C) receptors

AU - Callahan, P. M.

AU - Cunningham, Kathryn

PY - 1995

Y1 - 1995

N2 - The present study assessed compounds displaying affinity for 5-HT(1A), 5- HT(1B), 5-HT(2A) and 5-HT(2C) receptors for their ability to substitute for, enhance or antagonize the discriminative stimulus effects of cocaine (10 mg/kg) in rats. In substitution tests, the 5-HT(1A) receptor agonist 8- hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT; 0.2-1.6 mg/kg), the 5- HT(1A/B) receptor agonists RU 24969 (0.25-2 mg/kg) and CGS 12066B (2-16 mg/kg), the 5-HT(1B/2C) receptor agonists m-chlorophenylpiperazine (mCPP; 0.25-2 mg/kg) and m-trifluoromethylphenylpiperazine (TFMPP; 0.125-2 mg/kg), the 5-HT(2A/2C) receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2- aminopropane ([±]-DOB; 0.0625-0.5 mg/kg), the 5-HT(2C) receptor agonist MK 212 (0.25-1 mg/kg) and the nonselective 5-HT receptor agonist quipazine (1-8 mg/kg) engendered 30% to 70% cocaine-appropriate responding. The DA receptor antagonists SCH 23390 (0.025 or 0.05 mg/kg) and haloperidol (0.125 or 0.25 mg/kg) failed to block the partial substitution of RU 24969 (1 mg/kg) for cocaine. In combination tests, a fixed dose of either quipazine (4 mg/kg), RU 24969 (0.25, 0.5 or 1 mg/kg) or TFMPP (0.5 mg/kg) but not 8-OH-DPAT (0.4 mg/kg) or CGS 12066B (16 mg/kg) produced a leftward shift in the cocaine dose-response curve (0.625-5 mg/kg). In contrast, coadministration of either mCPP (0.25-2 mg/kg) or MK 212 (0.125-2 mg/kg) plus a dose of cocaine (5 mg/kg) that produced >85% cocaine-appropriate responding when given alone partially antagonized cocaine; mCPP (1 mg/kg) also produced a rightward shift in the cocaine dose-response curve. Neither 8-OH-DPAT (0.2-1.6 mg/kg), (±)- DOB (0.125-0.5 mg/kg) nor quipazine (2-8 mg/kg) blocked the cocaine stimulus. The 5-HT(1A) receptor antagonist NAN 190 (0.2-0.8 mg/kg), the 5-HT(2A/2C) receptor antagonist LY 53857 (0.5-4 mg/kg) and the 5-HT/DA receptor antagonist pirenperone (0.5-4 mg/kg) neither substituted for nor enhanced cocaine; however, pirenperone but not NAN 190 or LY 53857 partially blocked the cocaine (10 mg/kg) response. Although 5-HT receptor compounds do not substitute for cocaine, several 5-HT receptor agonists (i.e., the indole derivative RU 24969 and the arylpiperazines mCPP, MK 212, TFMPP and quipazine), but not antagonists, differentially modulate the stimulus effects of cocaine. Moreover, 5-HT(1B) and 5-HT(2C) receptors may be responsible for the observed enhancements and antagonisms, respectively, produced by the 5- HT receptor compounds, whereas 5-HT(1A) and 5-HT(2A) receptors do not appear to modulate the cocaine discrimination in rats.

AB - The present study assessed compounds displaying affinity for 5-HT(1A), 5- HT(1B), 5-HT(2A) and 5-HT(2C) receptors for their ability to substitute for, enhance or antagonize the discriminative stimulus effects of cocaine (10 mg/kg) in rats. In substitution tests, the 5-HT(1A) receptor agonist 8- hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT; 0.2-1.6 mg/kg), the 5- HT(1A/B) receptor agonists RU 24969 (0.25-2 mg/kg) and CGS 12066B (2-16 mg/kg), the 5-HT(1B/2C) receptor agonists m-chlorophenylpiperazine (mCPP; 0.25-2 mg/kg) and m-trifluoromethylphenylpiperazine (TFMPP; 0.125-2 mg/kg), the 5-HT(2A/2C) receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2- aminopropane ([±]-DOB; 0.0625-0.5 mg/kg), the 5-HT(2C) receptor agonist MK 212 (0.25-1 mg/kg) and the nonselective 5-HT receptor agonist quipazine (1-8 mg/kg) engendered 30% to 70% cocaine-appropriate responding. The DA receptor antagonists SCH 23390 (0.025 or 0.05 mg/kg) and haloperidol (0.125 or 0.25 mg/kg) failed to block the partial substitution of RU 24969 (1 mg/kg) for cocaine. In combination tests, a fixed dose of either quipazine (4 mg/kg), RU 24969 (0.25, 0.5 or 1 mg/kg) or TFMPP (0.5 mg/kg) but not 8-OH-DPAT (0.4 mg/kg) or CGS 12066B (16 mg/kg) produced a leftward shift in the cocaine dose-response curve (0.625-5 mg/kg). In contrast, coadministration of either mCPP (0.25-2 mg/kg) or MK 212 (0.125-2 mg/kg) plus a dose of cocaine (5 mg/kg) that produced >85% cocaine-appropriate responding when given alone partially antagonized cocaine; mCPP (1 mg/kg) also produced a rightward shift in the cocaine dose-response curve. Neither 8-OH-DPAT (0.2-1.6 mg/kg), (±)- DOB (0.125-0.5 mg/kg) nor quipazine (2-8 mg/kg) blocked the cocaine stimulus. The 5-HT(1A) receptor antagonist NAN 190 (0.2-0.8 mg/kg), the 5-HT(2A/2C) receptor antagonist LY 53857 (0.5-4 mg/kg) and the 5-HT/DA receptor antagonist pirenperone (0.5-4 mg/kg) neither substituted for nor enhanced cocaine; however, pirenperone but not NAN 190 or LY 53857 partially blocked the cocaine (10 mg/kg) response. Although 5-HT receptor compounds do not substitute for cocaine, several 5-HT receptor agonists (i.e., the indole derivative RU 24969 and the arylpiperazines mCPP, MK 212, TFMPP and quipazine), but not antagonists, differentially modulate the stimulus effects of cocaine. Moreover, 5-HT(1B) and 5-HT(2C) receptors may be responsible for the observed enhancements and antagonisms, respectively, produced by the 5- HT receptor compounds, whereas 5-HT(1A) and 5-HT(2A) receptors do not appear to modulate the cocaine discrimination in rats.

UR - http://www.scopus.com/inward/record.url?scp=0029100991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029100991&partnerID=8YFLogxK

M3 - Article

VL - 274

SP - 1414

EP - 1424

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -